Literature DB >> 3390864

The hormone-binding domains of the estrogen and glucocorticoid receptors contain an inducible transcription activation function.

N J Webster1, S Green, J R Jin, P Chambon.   

Abstract

We have constructed novel chimeric receptors, GAL-ER and GAL-GR, consisting of the DNA-binding domain of the yeast transcription factor GAL4 joined to the C-terminal region containing the hormone-binding domain of either the human estrogen (hER) or human glucocorticoid (hGR) receptor. Stimulation of transcription by GAL-ER and GAL-GR from GAL4-responsive reporter genes was hormone dependent, and the activation function has been localized to the hER or hGR region. Both chimeric receptors recognized GAL4-responsive elements only in the presence of hormone or anti-hormone, yet solely the hormone was capable of stimulating transcription. These and additional results suggest that the hormone plays at least a dual role. First, the hormone, or anti-hormone, is responsible for receptor "transformation" allowing the recognition of responsive DNA elements. Second, the hormone, but not the anti-hormone, can induce a transcription activation function present in the region that contains the hormone-binding domain.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3390864     DOI: 10.1016/0092-8674(88)90552-1

Source DB:  PubMed          Journal:  Cell        ISSN: 0092-8674            Impact factor:   41.582


  131 in total

1.  A GATA-2/estrogen receptor chimera functions as a ligand-dependent negative regulator of self-renewal.

Authors:  C Heyworth; K Gale; M Dexter; G May; T Enver
Journal:  Genes Dev       Date:  1999-07-15       Impact factor: 11.361

2.  Intranuclear localization of human papillomavirus 16 E7 during transformation and preferential binding of E7 to the Rb family member p130.

Authors:  K Smith-McCune; D Kalman; C Robbins; S Shivakumar; L Yuschenkoff; J M Bishop
Journal:  Proc Natl Acad Sci U S A       Date:  1999-06-08       Impact factor: 11.205

3.  Differential modes of activation define orphan subclasses within the steroid/thyroid receptor superfamily.

Authors:  J P Lydon; R F Power; O M Conneely
Journal:  Gene Expr       Date:  1992

Review 4.  Clinical pharmacokinetics of endocrine agents used in advanced breast cancer.

Authors:  P E Lønning; E A Lien; S Lundgren; S Kvinnsland
Journal:  Clin Pharmacokinet       Date:  1992-05       Impact factor: 6.447

5.  Effects of antioestrogens on the DNA binding activity of oestrogen receptors in vitro.

Authors:  N D Arbuckle; S Dauvois; M G Parker
Journal:  Nucleic Acids Res       Date:  1992-08-11       Impact factor: 16.971

Review 6.  Diversity in genetic in vivo methods for protein-protein interaction studies: from the yeast two-hybrid system to the mammalian split-luciferase system.

Authors:  Bram Stynen; Hélène Tournu; Jan Tavernier; Patrick Van Dijck
Journal:  Microbiol Mol Biol Rev       Date:  2012-06       Impact factor: 11.056

7.  The indirect association of human T-cell leukemia virus tax protein with DNA results in transcriptional activation.

Authors:  J Fujisawa; M Toita; T Yoshimura; M Yoshida
Journal:  J Virol       Date:  1991-08       Impact factor: 5.103

8.  Antiestrogen can establish nonproductive receptor complexes and alter chromatin structure at target enhancers.

Authors:  T A Pham; J F Elliston; Z Nawaz; D P McDonnell; M J Tsai; B W O'Malley
Journal:  Proc Natl Acad Sci U S A       Date:  1991-04-15       Impact factor: 11.205

9.  Fusion of adenovirus E1A to the glucocorticoid receptor by high-resolution deletion cloning creates a hormonally inducible viral transactivator.

Authors:  D M Becker; S M Hollenberg; R P Ricciardi
Journal:  Mol Cell Biol       Date:  1989-09       Impact factor: 4.272

Review 10.  Minireview: liver X receptor beta: emerging roles in physiology and diseases.

Authors:  Chiara Gabbi; Margaret Warner; Jan-Ake Gustafsson
Journal:  Mol Endocrinol       Date:  2008-12-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.